Tag: pharmacokinetic endpoints
Crossover Trial Design: How Bioequivalence Studies Are Structured
- 31.12.2025
- Posted in Health
- 10 Comments
Crossover trial designs are the standard method for proving generic drugs are bioequivalent to brand-name versions. They reduce sample sizes, improve accuracy, and are required by the FDA and EMA for most bioequivalence studies.
